Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies

Research output: Contribution to journalComment/debatepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies'. Together they form a unique fingerprint.